Business Description
IntelliPharmaCeutics International Inc
NAICS : 325412
SIC : 3741
ISIN : CA4581731011
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -8.22 | |||||
Debt-to-Equity | -0.17 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -111.84 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.9 | |||||
3-Year EBITDA Growth Rate | 40 | |||||
3-Year EPS without NRI Growth Rate | 35.8 | |||||
3-Year FCF Growth Rate | 48.5 | |||||
3-Year Book Growth Rate | -24.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.26 | |||||
9-Day RSI | 47.72 | |||||
14-Day RSI | 47.32 | |||||
6-1 Month Momentum % | -13.59 | |||||
12-1 Month Momentum % | -14.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.03 | |||||
Days Sales Outstanding | 73.44 | |||||
Days Payable | 78681.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.4 | |||||
Shareholder Yield % | -18.68 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.03 | |||||
Operating Margin % | -279.12 | |||||
Net Margin % | -350.12 | |||||
FCF Margin % | 11.81 | |||||
ROA % | -205.83 | |||||
ROIC % | -77.92 | |||||
ROC (Joel Greenblatt) % | -349.02 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.16 | |||||
Price-to-Free-Cash-Flow | 11.43 | |||||
Price-to-Operating-Cash-Flow | 11.43 | |||||
EV-to-EBIT | -1.32 | |||||
EV-to-EBITDA | -1.41 | |||||
EV-to-Revenue | 4.2 | |||||
EV-to-FCF | 31.3 | |||||
Price-to-Median-PS-Value | 0.32 | |||||
Earnings Yield (Greenblatt) % | -75.76 | |||||
FCF Yield % | 6.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.838 | ||
EPS (TTM) (€) | -0.086 | ||
Beta | 3.17 | ||
Volatility % | 158.35 | ||
14-Day RSI | 47.32 | ||
14-Day ATR (€) | 0.000088 | ||
20-Day SMA (€) | 0.0445 | ||
12-1 Month Momentum % | -14.09 | ||
52-Week Range (€) | 0.0245 - 0.082 | ||
Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IntelliPharmaCeutics International Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(FRA:I4AA)'s stock price today?
When is next earnings date of IntelliPharmaCeutics International Inc(FRA:I4AA)?
Does IntelliPharmaCeutics International Inc(FRA:I4AA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |